Drug Classification
This group unites drugs that vary in heterocyclic ring structure but share a similar pharmacological effect. There are two main subgroups:
- Thiazide diuretics (benzothiadiazine derivatives):
- Hydrochlorothiazide (Hypothiazide);
- Cyclopenthiazide.
- Thiazide-like diuretics (representatives of various chemical groups):
- Indapamide;
- Chlorthalidone;
- Clopamide.
All of these agents are well absorbed from the gastrointestinal tract following oral administration, and their efficacy remains preserved regardless of the blood acid-base status (in both acidosis and alkalosis). They are excreted by the kidneys and gastrointestinal tract.
Mechanism of Action and Urine Ionogram
The site of action of thiazides is the renal tubular epithelium, specifically the early segment of the distal convoluted tubule.
These drugs inhibit the $Na^+$-$Cl^-$-cotransporter (NCC system) on the luminal (apical) membrane of tubular epithelial cells. This disrupts the transport system responsible for sodium and chloride reabsorption. As a result of impaired electrolyte reabsorption, water follows osmotically, increasing diuresis.
Changes in the Urine Ionogram:
- $Na^+$ and $Cl^-$: excretion significantly increases (this is the primary, direct effect).
- $K^+$: excretion increases secondarily as a consequence of blocked sodium reabsorption.
- $Ca^{2+}$: excretion decreases. The drugs upregulate TRPV5 calcium channels on the luminal membrane, leading to calcium retention in the body.
Clinical Indications
Thiazides are highly effective and widely used in clinical practice. The main indications include:
- Hypertension. These are first-line agents with high antihypertensive efficacy. The blood pressure-lowering mechanism is dual: first, the diuretic effect reduces extracellular fluid volume and circulating blood volume; second, there is an additional vasodilatory effect. This is thought to result from decreased sodium content in the vascular wall, which reduces vascular reactivity.
- Edematous States. Prescribed for heart failure (HF), as well as liver and kidney disorders.
- Nephrolithiasis (Kidney Stones). Due to their ability to reduce urinary calcium excretion, thiazides are used to prevent the formation of insoluble calcium stones in patients with idiopathic hypercalciuria.
- Nephrogenic Diabetes Insipidus. In this condition, the drugs exert a paradoxical effect — they reduce urine output.
- Glaucoma. Used in certain specific clinical settings.
Characteristics of Individual Agents
Hydrochlorothiazide The prototype drug of the class. Well absorbed from the GI tract. Action begins in 30–60 minutes, peaks at 2 hours, and lasts 8–12 hours. Administered once daily. It is a first-line drug for hypertension and can be used as monotherapy. Side effects: nausea, fatigue, hypokalemia, hypomagnesemia, hyperuricemia (elevated uric acid), and hyperglycemia.
Cyclopenthiazide Structurally similar to hydrochlorothiazide, but 50 times more potent, thus used in smaller doses. Onset of action is 2–4 hours, peak effect is at 3–6 hours, and average duration is 10–12 hours.
Indapamide An effective diuretic with an independent antihypertensive effect that is not directly tied to diuresis. The elimination half-life ($T_{1/2}$) is 18 hours. Specific side effect: orthostatic hypotension may occur.
Long-Acting Agents
- Chlorthalidone: notable for its exceptionally long duration of action (up to 72 hours), allowing a dosing schedule of 2–3 times per week.
- Clopamide: highly potent, acts for up to 18 hours, administered once daily.